These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9476868)

  • 1. The mechanism by which epinastine stops an adenosine analog from contracting BDE rat airways.
    Meade CJ
    Am J Respir Crit Care Med; 1998 Feb; 157(2):522-30. PubMed ID: 9476868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo role of the adenosine A3 receptor: N6-2-(4-aminophenyl)ethyladenosine induces bronchospasm in BDE rats by a neurally mediated mechanism involving cells resembling mast cells.
    Meade CJ; Mierau J; Leon I; Ensinger HA
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1148-56. PubMed ID: 8968336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epinastine (WAL 801CL) modulates the noncholinergic contraction in guinea-pig airways in vitro by a prejunctional 5-HT1-like receptor.
    Dupont LJ; Meade CJ; Demedts MG; Verleden GM
    Eur Respir J; 1996 Jul; 9(7):1433-8. PubMed ID: 8836655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epinastine (WAL 801CL) inhibits the electrical field stimulation-induced cholinergic contraction in guinea pig and human airways in vitro.
    Dupont LJ; Pype JL; Meade CJ; DeLeyn P; Deneffe G; Demedts MG; Verleden GM
    Eur Respir J; 1999 Nov; 14(5):1068-75. PubMed ID: 10596692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of granulocytes in the lung and skin of guinea pigs. Inhibition by the anti-H1 antiallergic agent epinastine.
    Fügner A; Meissner C
    Arzneimittelforschung; 1994 Dec; 44(12):1338-42. PubMed ID: 7848354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiallergic effect of epinastine (WAL 801 CL) on immediate hypersensitivity reactions: (II). Antagonistic effect of epinastine on chemical mediators, mainly antihistaminic and anti-PAF effects.
    Kamei C; Mio M; Kitazumi K; Tsujimoto S; Yoshida T; Adachi Y; Tasaka K
    Immunopharmacol Immunotoxicol; 1992; 14(1-2):207-18. PubMed ID: 1350791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of epinastine on bronchoconstriction induced by histamine, platelet activating factor and serotonin in guinea pigs and rats.
    Tasaka K; Kamei C; Nakamura S
    Arzneimittelforschung; 1994 Mar; 44(3):327-9. PubMed ID: 7910745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihistaminic activity and side effect profile of epinastine and terfenadine in healthy volunteers.
    Schilling JC; Adamus WS; Kuthan H
    Int J Clin Pharmacol Ther Toxicol; 1990 Dec; 28(12):493-7. PubMed ID: 1982280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiallergic effect of epinastine (WAL 801 CL) on immediate hypersensitivity reactions: (I). Elucidation of the mechanism for histamine release inhibition.
    Kamei C; Akagi M; Mio M; Kitazumi K; Izushi K; Masaki S; Tasaka K
    Immunopharmacol Immunotoxicol; 1992; 14(1-2):191-205. PubMed ID: 1375955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro investigations with the histamine H1 receptor antagonist, epinastine (WAL 801 CL), on isolated human allergic effector cells.
    Amon U; Gibbs BF; Buss G; Nitschke M
    Inflamm Res; 2000 Mar; 49(3):112-6. PubMed ID: 10807498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermal objective pharmacodynamic profile of cetirizine and epinastine: two controlled, randomised, double-blind, crossover studies.
    Leroy T; van Neste D
    Int J Clin Pract; 2002 Oct; 56(8):568-73. PubMed ID: 12425364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of epinastine on the antitussive and rewarding effects of dihydrocodeine in mice.
    Kamei J; Morita K; Ohsawa M; Onodera K
    Methods Find Exp Clin Pharmacol; 1999 Dec; 21(10):663-8. PubMed ID: 10702962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo studies of the non-sedating antihistamine epinastine.
    Fügner A; Bechtel WD; Kuhn FJ; Mierau J
    Arzneimittelforschung; 1988 Oct; 38(10):1446-53. PubMed ID: 2461715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the new antiallergic drug epinastine on chemical mediator induced bronchoconstrictions in guinea pigs.
    Misawa M; Kanai Y
    Arzneimittelforschung; 1991 Nov; 41(11):1145-9. PubMed ID: 1725697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influx and efflux transport of H1-antagonist epinastine across the blood-brain barrier.
    Ishiguro N; Nozawa T; Tsujihata A; Saito A; Kishimoto W; Yokoyama K; Yotsumoto T; Sakai K; Igarashi T; Tamai I
    Drug Metab Dispos; 2004 May; 32(5):519-24. PubMed ID: 15100174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of anti-allergic activities of the histamine H1 receptor antagonists epinastine, ketotifen and oxatomide in human leukocytes.
    Mita H; Shida T
    Arzneimittelforschung; 1995 Jan; 45(1):36-40. PubMed ID: 7893266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of the antihistamines epinastine, terfenadine, and ebastine on potassium currents in rat ventricular myocytes.
    Ohtani H; Hanada E; Hirota M; Sato H; Kotaki H; Sawada Y; Uemura H; Nakaya H; Iga T
    J Pharm Pharmacol; 1999 Sep; 51(9):1059-63. PubMed ID: 10528990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epinastine: topical ophthalmic second generation antihistamine without significant systemic side effects.
    Pradhan S; Abhishek K; Mah F
    Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1135-40. PubMed ID: 19630694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of pharmacological properties of optical isomers and a racemic mixture of epinastine.
    Tasaka K; Kamei C; Izushi K; Tsujimoto S; Yoshida T
    Arzneimittelforschung; 1991 Mar; 41(3):219-23. PubMed ID: 1714277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomographic study of central histamine H1-receptor occupancy in human subjects treated with epinastine, a second-generation antihistamine.
    Yanai K; Ryu JH; Watanabe T; Iwata R; Ido T; Asakura M; Matsumura R; Itoh M
    Methods Find Exp Clin Pharmacol; 1995 Nov; 17 Suppl C():64-9. PubMed ID: 8750798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.